EICHOR

Recruiting studies: Relapsed Small Cell Lung Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer
Phase 1 · 3 location(s) · Nerviano Medical Sciences · NCT06931626 Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Phase 1 · 30 location(s) · Calico Life Sciences LLC · NCT04777994 A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)
Phase 3 · 126 location(s) · GlaxoSmithKline · NCT07099898 A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relaps
Phase 1/Phase 2 · 12 location(s) · Bristol-Myers Squibb · NCT07325136 First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non
Phase 1/Phase 2 · 1 location(s) · Washington University School of Medicine · NCT07355205 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Phase 1/Phase 2 · 4 location(s) · Radiopharm Theranostics, Ltd · NCT07189871 A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)
Phase 1 · 37 location(s) · Aurigene Discovery Technologies Limited · NCT05865002 A Machine Learning Approach to Identify Patients With Resected Non-small-cell Lung Cancer With High Risk of Relapse
Phase N/A · 1 location(s) · University Hospital, Toulouse · NCT05732974 Combined Relapse Prediction Model for Resectable Non-Small Cell Patients - a Prospective Clinical Feasibility Trial
NA · 1 location(s) · Chang Gung Memorial Hospital · NCT06262386 TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC
EARLY_Phase 1 · 1 location(s) · TCRCure Biopharma Ltd. · NCT07246304 Lurbinectedin or in Combination with Irinotecan Versus Topotecan in Patients with Relapsed SCLC
Phase 3 · 1 location(s) · Luye Pharma Group Ltd. · NCT06496048 Randomized Trial Comparing Standard of Care Versus Immune- Based Combination in Relapsed Stage III Non-small-cell Lung C
Phase 2 · 1 location(s) · Fondazione Ricerca Traslazionale · NCT05568212 Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
Phase 1/Phase 2 · 11 location(s) · VA Office of Research and Development · NCT06681220 Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor
Phase 2 · 15 location(s) · Genelux Corporation · NCT06463665 Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT07410494 Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)
Phase 1/Phase 2 · 1 location(s) · Beijing Biotech · NCT07480213 Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
Phase 2 · 5 location(s) · Dwight Owen · NCT04919382 A Phase IIII Study of AL8326 in Small Cell Lung Cancer
Phase 3 · 1 location(s) · Advenchen Laboratories Nanjing Ltd. · NCT06247605 A Randomised Trial of Chemotherapy Plus Surgery for Recurrent Non-Small Cell Lung Cancer
Phase 1 · 3 location(s) · Shanghai Jiao Tong University School of Medicine · NCT02889666 A Study Evaluating The Combination of Immunotherapy With Radiotherapy in Non-Small Cell Lung Cancer
Phase 2 · 1 location(s) · University of Chicago · NCT07603856 MRD Monitoring in Lung Cancer After Resection
Phase N/A · 1 location(s) · Guangdong Provincial People's Hospital · NCT04976296 APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Phase 2 · 35 location(s) · Apollomics Inc. · NCT03175224 Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLC
NA · 1 location(s) · Fudan University · NCT06258642 A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants Wit
Phase 1/Phase 2 · 48 location(s) · Merck Sharp & Dohme LLC · NCT06780137 Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer
Phase 3 · 1 location(s) · Suzhou Zelgen Biopharmaceuticals Co.,Ltd · NCT07189455 Phase I Clinical Study of α-PD-L1/DLL3 CAR-T in Patients With R/R SCLC
Phase 1 · 1 location(s) · Sichuan University · NCT06348797 Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer
Phase 1 · 1 location(s) · SciTech Development, Inc. · NCT06922539 A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Phase 3 · 1 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT06954246 A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Phase 1 · 10 location(s) · Dren Bio · NCT06999187 This Study is an Open-lable, Early Study to Evaluate the Safety, Feasibility, Cytokinetics, and Preliminary Efficacy of
Phase 1 · 2 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07249879

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →